Advertisement

Annular Rash in a Neonate

  • Yan Ling Kong
  • Emily Yiping Gan
Chapter

Abstract

  • Neonatal lupus erythematosus (NLE) is an acquired autoimmune disease resulting from the transplacental passage of maternal antibodies

  • NLE is characterized by the presence of annular erythematous plaques seen predominantly on the face and scalp

  • Anti-Ro/SSA antibody in the most common auto-antibody found in patients with NLE

  • Other associated antibodies include anti-La/SSB and anti-U1RNP antibodies

  • Life-threatening cardiac conduction defects commonly occurs in NLE

  • Pacemaker insertion is usually required for patients with NLE and congenital heart block

  • Use of hydroxychloroquine decreases the risk of cardiac NLE in subsequent offspring, but not the non-cardiac manifestations of NLE

Keywords

Neonatal lupus erythematosus Anti-Ro Congenital heart block 

References

  1. 1.
    Mccuistion CH. Possible discoid lupus erythematosus in newborn infant. Report of a case with subsequent development of acute systemic lupus erythematosus in mother. Arch Dermatol. 1983;119(7):615–8.CrossRefGoogle Scholar
  2. 2.
    Lee LA. Neonatal lupus: clinical features and management. Pediatr Drugs. 2004;6(2):71–8.CrossRefGoogle Scholar
  3. 3.
    Silverman E, Jaeggi E. Non-cardiac manifestations of neonatal lupus erythematosus. Scand J Immunol. 2010;14(72):3.Google Scholar
  4. 4.
    Lee LA. The clinical spectrum of neonatal lupus. Arch Dermatol Res. 2008;301(1):107–10.CrossRefGoogle Scholar
  5. 5.
    Eftekhari P, Salle L, Lezoualc’h F, Mialet J, Gastineau M, Briand JP, Isenberg DA, Fournie GJ, Argibay J, Fischmeister R, Muller S, Hoebeke J. Anti-SSA/Ro52 autoantibodies blocking the cardiac 5-HT4 serotoninergic receptor could explain neonatal lupus congenital heart block. Eur J Immunol. 2000;30(10):2782–90.CrossRefGoogle Scholar
  6. 6.
    Cimaz R, Spence DL, Hornberg L, Silverman ED. Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies. J Pediatr. 2003;142(6):678–83.CrossRefGoogle Scholar
  7. 7.
    Hon KL, Leung AKC. Neonatal lupus erythematosus. Autoimmune Dis. 2012;2012:301274.PubMedGoogle Scholar
  8. 8.
    Rivera TLI, Izmirly PM, Birnbaum BK, Byrne P, Brauth JB, Katholi M, Kim MY, Fischer J, Clancy RM, Buyon JP. Disease progression in mothers of children enrolled in the Research Registry for Neonatal Lupus. Ann Rheum Dis. 2009;68(6):828–35.CrossRefGoogle Scholar
  9. 9.
    Friedman DM, Kim MY, Copel JA, Davis C, Phoon CK, Glickstein JS, Buyon JP. Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study. Circulation. 2008;117(4):485–93.CrossRefGoogle Scholar
  10. 10.
    Skog A, Wahren-Herlenius M, Sundstrom B, Bremme K, Sonesson SE. Outcome and growth of infants fetally exposed to heart block-associated maternal anti-Ro52/SSA autoantibodies. Pediatrics. 2008;121(4):e803–9.CrossRefGoogle Scholar
  11. 11.
    Lee L. Cutaneous lupus in infancy and childhood. Lupus. 2010;19(9):1112–7.CrossRefGoogle Scholar
  12. 12.
    Guettrot-Imbert G, Cohen L, Fermont L, Villain E, Frances C, Thiebaugeorges O, Foliguet B, Leroux G, Cacoub P, Amoura Z, Piette JC, Costedoat-Chalumeau N. A new presentation of neonatal lupus: 5 cases of isolated mild endocardial fibroelastosis associated with maternal Anti-SSA/Ro and Anti-SSB/La antibodies. J Rheumatol. 2011;38(2):378–86.CrossRefGoogle Scholar
  13. 13.
    Barsalou J, Jaeggi E, Laskin CA, Brown P, Tian SY, Hamilton RM, Silverman ED. Prenatal exposure to antimalarials decreases the risk of cardiac but not non-cardiac neonatal lupus: a single-centre cohort study. Rheumatology (Oxford). 2017;56(9):1552–9.CrossRefGoogle Scholar
  14. 14.
    Shinohara K. Neonatal lupus erythematosus: results of maternal corticosteroid therapy. Obstet Gynecol. 1999;93(6):952–7.PubMedGoogle Scholar
  15. 15.
    Saleeb S, Copel J, Friedman D, Buyon JP. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus. Arthritis Rheum. 1999;42(11):2335–45.CrossRefGoogle Scholar
  16. 16.
    Klauninger R, Skog A, Horvath L, Winqvist O, Edner A, Bremme K, Sonesson SE, Wahren-Herlenius M. Serologic follow-up of children born to mothers with Ro/SSA autoantibodies. Lupus. 2009;18(9):792–8.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Yan Ling Kong
    • 1
  • Emily Yiping Gan
    • 2
  1. 1.National Skin CentreSingaporeSingapore
  2. 2.Dermatology ServiceKK Women’s and Children’s HospitalSingaporeSingapore

Personalised recommendations